Advaxis, Inc. (ADXS)
| Market Cap | 52.43M |
| Revenue (ttm) | 3.24M |
| Net Income (ttm) | -18.88M |
| Shares Out | 145.64M |
| EPS (ttm) | -0.17 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,671,911 |
| Open | 0.343 |
| Previous Close | 0.354 |
| Day's Range | 0.340 - 0.366 |
| 52-Week Range | 0.300 - 1.570 |
| Beta | 2.22 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About ADXS
Advaxis, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) technology antigen delivery products in the United States. The company is developing ADXS-PSA, which is in Phase 2 clinical trials for the treatment of metastatic prostate cancer; ADXS-503 that is in Phase 1/2 clinical trials for the treatment of non-small cell lung cancer; and ADXS-504 for the treatment of prostate cancer. It is also conducting clinical studies of Lm Technology immunothe...
Financial Performance
Financial StatementsNews
Advaxis Issues Letter and Second Video Message to Stockholders Regarding Upcoming Special Meeting
Company releases video message highlighting the need for all proposals to pass in order to consummate the proposed Biosight transaction
Nasdaq Grants Advaxis, Inc. an Extension to December 20, 2021, to Complete Merger Transaction with Biosight, Ltd. and...
MONMOUTH JUNCTION, N.J., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Advaxis, Inc. (Nasdaq: ADXS) (“Advaxis” or the “Company”), a clinical-stage biotechnology company focused on the development and commercializat...
Advaxis, Inc. Issues Letter to Stockholders
Advaxis urges stockholders to carefully evaluate the potential outcomes of the vote on the proposed merger with Biosight and vote FOR all proposals Advaxis urges stockholders to carefully evaluate the p...
Leading Independent Proxy Advisory Firm Glass Lewis Joins ISS in Recommending Advaxis Stockholders Vote “FOR” Propose...
Advaxis urges stockholders to vote “FOR” the merger with Biosight and all proposals Advaxis urges stockholders to vote “FOR” the merger with Biosight and all proposals
Biosight Encourages Advaxis Stockholders to Vote “FOR” Proposed Merger
Combined company, to be named Biosight Therapeutics, expected to be well-positioned to leverage its compelling oncology therapeutics pipeline, strong cash position, and accomplished management and Board...
3 Hot Penny Stocks That Retail Traders Are Watching Right Now
Why retail traders are watching these penny stocks right now The post 3 Hot Penny Stocks That Retail Traders Are Watching Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | P...
Advaxis Issues Letter and Video Message to Stockholders Regarding Upcoming Special Meeting
Company releases video message highlighting strategic rationale and benefits of proposed Biosight transaction for Advaxis stockholders
Leading Independent Proxy Advisory Firm ISS Recommends Advaxis Stockholders Vote “FOR” the Merger with Biosight
MONMOUTH JUNCTION, N.J., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Advaxis, Inc. (Nasdaq: ADXS), a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products...
Top Penny Stocks to Buy From TikTok? 3 That Investors Are Watching
These penny stocks are popular on TikTok, are they on your watchlist? The post Top Penny Stocks to Buy From TikTok?
6 of the Hottest Stocks to Pick Up for Less Than $1
These penny stocks are trading for under a dollar, but could change that in the coming months with their strong fundamentals. The post 6 of the Hottest Stocks to Pick Up for Less Than $1 appeared first ...
Best Penny Stocks to Buy Next Month? 3 You Need to Know About
Which penny stocks are on your November watchlist? The post Best Penny Stocks to Buy Next Month?
Top Trending Penny Stocks to Watch Next Month
With so many trending penny stocks to buy, which small caps are you watching? The post Top Trending Penny Stocks to Watch Next Month appeared first on Penny Stocks to Buy, Picks, News and Information | ...
3 Trending Penny Stocks For Your Small-Caps Watchlist Right Now
These trending penny stocks could be worth adding to your October watchlist, here's why The post 3 Trending Penny Stocks For Your Small-Caps Watchlist Right Now appeared first on Penny Stocks to Buy, Pi...
Top Biotech Penny Stocks to Watch With High Volume Right Now
Are these high volume biotech penny stocks worth adding to your watchlist right now? The post Top Biotech Penny Stocks to Watch With High Volume Right Now appeared first on Penny Stocks to Buy, Picks, N...
3 Tech Penny Stocks to Watch During the Market Crash
Can tech penny stocks perform well amidst today's stock market crash? The post 3 Tech Penny Stocks to Watch During the Market Crash appeared first on Penny Stocks to Buy, Picks, News and Information | P...
Hot Penny Stocks to Add to Your September Watchlist
Why investors are watching these 3 penny stocks right now The post Hot Penny Stocks to Add to Your September Watchlist appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Advaxis Reports 3rd Quarter Ended July 31, 2021 Financial Results and Provides a Business Update
Entered definitive merger agreement with Biosight Ltd. to advance pipeline of clinical-stage oncology programs for solid tumors and hematological malignancies
3 Penny Stocks That Top Investors Are Watching Right Now
Why top investors are watching these penny stocks right now The post 3 Penny Stocks That Top Investors Are Watching Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennySt...
Trending Penny Stocks to Buy in September? Check These 3 Out
Are these penny stocks on your September small-caps watchlist? The post Trending Penny Stocks to Buy in September?
Nasdaq Grants Advaxis, Inc. an Extension to November 22, 2021, to Regain Compliance with the $1.00 Minimum Bid Price ...
MONMOUTH JUNCTION, N.J., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Advaxis, Inc. (Nasdaq: ADXS) (“Advaxis” or the “Company”), a clinical-stage biotechnology company focused on the development and commercializat...
Popular Penny Stocks to Buy in 2021? Here's 4 You Should Know About
Why These 3 Penny Stocks Are Popular Among Traders Right Now The post Popular Penny Stocks to Buy in 2021? Here's 4 You Should Know About appeared first on Penny Stocks to Buy, Picks, News and Informati...
Hot Penny Stocks to Buy Now? 6 Reopening Stocks To Watch In July 2021
Reopening penny stocks are showing momentum right now; here's 6 to watch The post Hot Penny Stocks to Buy Now? 6 Reopening Stocks To Watch In July 2021 appeared first on Penny Stocks to Buy, Picks, News...
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Advaxis, Inc. - ADXS
NEW YORK, July 16, 2021 /PRNewswire/-- Juan Monteverde , founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018-2020 ISS Securities Class Action ...
Advaxis Kick Starts Early-Stage Study For Prostate Cancer Immunotherapy
Advaxis Inc (NASDAQ: ADXS) has initiated a Phase 1 study evaluating ADXS-504 in patients with recurrent prostate cancer. The study, being conducted at Columbia University Irving Medical Center, is the ...
Advaxis Announces Initiation of Phase 1 Clinical Trial of ADXS-504 for the Treatment of Early Prostate Cancer
Study in biochemically recurrent prostate cancer expands off-the-shelf ADXS-HOT program to second indication Study in biochemically recurrent prostate cancer expands off-the-shelf ADXS-HOT program to se...